19th Ave New York, NY 95822, USA

About EFIS

The European Federation of Immunological Societies (EFIS) is a non-profit umbrella organization that represents more than 14,000 individual immunologists from 35 immunological societies from all across Europe, and even beyond the borders to Israel.

The main goals of EFIS are the support of immunological research and education as well as strengthening scientific interaction amongst the members with:

  • supporting young scientists, e.g. through fellowships or travel grants.
  • supporting congresses and conferences in Europe
  • promoting Immunology to the general public through the Day of Immunology, and other activities: check out the interactive exhibition www.inside-immunity.org or the interactive book www.interactive-immunity.org

For more information about EFIS please visit www.efis.org

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.

eLife transforms research communication to create a future where a global community of researchers produces open and trusted results. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared.
We aim to review significant immunology research spanning allergy, immunity and immunoregulation, inflammation and T-cell receptor signalling. To read the latest Immunology and Inflammation research reviewed by eLife, visit our website.

No matter where you are in your drug development journey, Charles River can provide you with a wide range of products, models, services, and guidance that are tailored to your specific needs. Our biologic and manufacturing services help you navigate seamlessly throughout the drug development cycle with a wide variety of comprehensive CGMP testing and manufacturing solutions including monoclonal antibodies/recombinant proteins, viral vectors, vaccines, and cell therapies. With over 40,000 tests run annually at our global biologics testing facilities and 200+ products supported; you can count on our expertise to ensure your therapy is safe, effective, and able to pass regulatory scrutiny.

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.